Perrigo’s Generic Loratadine Offerings Could Boost Firm’s Cough/Cold Sales

Perrigo's planned introduction of two generic loratadine formulations in early 2004 is expected to improve the firm's lackluster cough/cold sales in the second half of its fiscal year